Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial : letter to the editor

Saved in:
Bibliographic Details
Main Authors: Ruhnke, Leo (Author) , Röllig, Christoph (Author) , Herold, Sylvia (Author) , Sauer, Tim (Author) , Brandts, Christian Hubertus (Author) , Steffen, Björn (Author) , Schäfer-Eckart, Kerstin (Author) , Krause, Stefan W. (Author) , Hänel, Mathias (Author) , Reichle, Albrecht (Author) , Scholl, Sebastian (Author) , Neubauer, Andreas (Author) , Mikesch, Jan-Henrik (Author) , Schetelig, Johannes (Author) , Stölzel, Friedrich (Author) , Kramer, Michael (Author) , Haake, Annett (Author) , Frimmel, Julia (Author) , Krämer, Alwin (Author) , Schlenk, Richard Friedrich (Author) , Platzbecker, Uwe (Author) , Serve, Hubert (Author) , Baldus, Claudia (Author) , Müller-Tidow, Carsten (Author) , Aust, Daniela E. (Author) , Bornhäuser, Martin (Author) , Ehninger, Gerhard (Author) , Thiede, Christian (Author)
Format: Article (Journal) Editorial
Language:English
Published: September, 2023
In: Haematologica
Year: 2023, Volume: 108, Issue: 9, Pages: 2520-2525
ISSN:1592-8721
DOI:10.3324/haematol.2022.281636
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2022.281636
Verlag, kostenfrei, Volltext: https://haematologica.org/article/view/haematol.2022.281636
Get full text
Author Notes:Leo Ruhnke, Christoph Röllig, Sylvia Herold, Tim Sauer, Christian H. Brandts, Björn Steffen, Kerstin Schäfer-Eckart, Stefan W. Krause, Mathias Hänel, Albrecht Reichle, Sebastian Scholl, Andreas Neubauer, Jan-Henrik Mikesch, Johannes Schetelig, Friedrich Stölzel, Michael Kramer, Annett Haake, Julia Frimmel, Alwin Krämer, Richard Schlenk, Uwe Platzbecker, Hubert Serve, Claudia D. Baldus, Carsten Müller-Tidow, Daniela Aust, Martin Bornhäuser, Gerhard Ehninger and Christian Thiede on behalf of the Study Alliance Leukemia (SAL)

MARC

LEADER 00000caa a2200000 c 4500
001 1880352532
003 DE-627
005 20240307024157.0
007 cr uuu---uuuuu
008 240208s2023 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2022.281636  |2 doi 
035 |a (DE-627)1880352532 
035 |a (DE-599)KXP1880352532 
035 |a (OCoLC)1425200670 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ruhnke, Leo  |d 1990-  |e VerfasserIn  |0 (DE-588)1187795550  |0 (DE-627)1666750395  |4 aut 
245 1 0 |a Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations  |b results of the SAL MIDOKIT trial : letter to the editor  |c Leo Ruhnke, Christoph Röllig, Sylvia Herold, Tim Sauer, Christian H. Brandts, Björn Steffen, Kerstin Schäfer-Eckart, Stefan W. Krause, Mathias Hänel, Albrecht Reichle, Sebastian Scholl, Andreas Neubauer, Jan-Henrik Mikesch, Johannes Schetelig, Friedrich Stölzel, Michael Kramer, Annett Haake, Julia Frimmel, Alwin Krämer, Richard Schlenk, Uwe Platzbecker, Hubert Serve, Claudia D. Baldus, Carsten Müller-Tidow, Daniela Aust, Martin Bornhäuser, Gerhard Ehninger and Christian Thiede on behalf of the Study Alliance Leukemia (SAL) 
264 1 |c September, 2023 
300 |b Illustrationen 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 9. Februar 2023 
500 |a Gesehen am 08.02.2024 
700 1 |a Röllig, Christoph  |d 1971-  |e VerfasserIn  |0 (DE-588)122493168  |0 (DE-627)705929116  |0 (DE-576)293296049  |4 aut 
700 1 |a Herold, Sylvia  |e VerfasserIn  |4 aut 
700 1 |a Sauer, Tim  |d 1981-  |e VerfasserIn  |0 (DE-588)138282013  |0 (DE-627)601099516  |0 (DE-576)307058166  |4 aut 
700 1 |a Brandts, Christian Hubertus  |d 1970-  |e VerfasserIn  |0 (DE-588)12042391X  |0 (DE-627)696662825  |0 (DE-576)178982164  |4 aut 
700 1 |a Steffen, Björn  |e VerfasserIn  |4 aut 
700 1 |a Schäfer-Eckart, Kerstin  |e VerfasserIn  |4 aut 
700 1 |a Krause, Stefan W.  |d 1959-  |e VerfasserIn  |0 (DE-588)124439565X  |0 (DE-627)1775638367  |4 aut 
700 1 |a Hänel, Mathias  |d 1964-  |e VerfasserIn  |0 (DE-588)17362295X  |0 (DE-627)698532414  |0 (DE-576)134465970  |4 aut 
700 1 |a Reichle, Albrecht  |e VerfasserIn  |4 aut 
700 1 |a Scholl, Sebastian  |d 1974-  |e VerfasserIn  |0 (DE-588)118915885X  |0 (DE-627)1667891693  |4 aut 
700 1 |a Neubauer, Andreas  |d 1963-  |e VerfasserIn  |0 (DE-588)136507689  |0 (DE-627)694432431  |0 (DE-576)30105522X  |4 aut 
700 1 |a Mikesch, Jan-Henrik  |d 1976-  |e VerfasserIn  |0 (DE-588)130115312  |0 (DE-627)490868096  |0 (DE-576)298005964  |4 aut 
700 1 |a Schetelig, Johannes  |d 1968-  |e VerfasserIn  |0 (DE-588)120026953  |0 (DE-627)696313138  |0 (DE-576)292002831  |4 aut 
700 1 |a Stölzel, Friedrich  |d 1978-  |e VerfasserIn  |0 (DE-588)136524966  |0 (DE-627)584491174  |0 (DE-576)284279307  |4 aut 
700 1 |a Kramer, Michael  |e VerfasserIn  |4 aut 
700 1 |a Haake, Annett  |e VerfasserIn  |4 aut 
700 1 |a Frimmel, Julia  |d 1991-  |e VerfasserIn  |0 (DE-588)1279116366  |0 (DE-627)1832386589  |4 aut 
700 1 |a Krämer, Alwin  |e VerfasserIn  |0 (DE-588)1067780025  |0 (DE-627)819183431  |0 (DE-576)426900820  |4 aut 
700 1 |a Schlenk, Richard Friedrich  |d 1965-  |e VerfasserIn  |0 (DE-588)129025380  |0 (DE-627)387778004  |0 (DE-576)297454102  |4 aut 
700 1 |a Platzbecker, Uwe  |e VerfasserIn  |0 (DE-588)115567089  |0 (DE-627)647686228  |0 (DE-576)337938695  |4 aut 
700 1 |a Serve, Hubert  |e VerfasserIn  |0 (DE-588)1169095399  |0 (DE-627)1032734256  |0 (DE-576)511922388  |4 aut 
700 1 |a Baldus, Claudia  |d 1972-  |e VerfasserIn  |0 (DE-588)122672631  |0 (DE-627)705995054  |0 (DE-576)293374945  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Aust, Daniela E.  |e VerfasserIn  |0 (DE-588)1043852360  |0 (DE-627)771001665  |0 (DE-576)174280815  |4 aut 
700 1 |a Bornhäuser, Martin  |d 1966-  |e VerfasserIn  |0 (DE-588)1167559118  |0 (DE-627)1031176071  |0 (DE-576)511198817  |4 aut 
700 1 |a Ehninger, Gerhard  |d 1952-  |e VerfasserIn  |0 (DE-588)135880483  |0 (DE-627)572475683  |0 (DE-576)300697287  |4 aut 
700 1 |a Thiede, Christian  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 108(2023), 9 vom: Sept., Seite 2520-2525  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations results of the SAL MIDOKIT trial : letter to the editor 
773 1 8 |g volume:108  |g year:2023  |g number:9  |g month:09  |g pages:2520-2525  |g extent:6  |a Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations results of the SAL MIDOKIT trial : letter to the editor 
856 4 0 |u https://doi.org/10.3324/haematol.2022.281636  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://haematologica.org/article/view/haematol.2022.281636  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240208 
993 |a Editorial 
994 |a 2023 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 24 
998 |g 129025380  |a Schlenk, Richard Friedrich  |m 129025380:Schlenk, Richard Friedrich  |d 910000  |d 910100  |e 910000PS129025380  |e 910100PS129025380  |k 0/910000/  |k 1/910000/910100/  |p 20 
998 |g 1067780025  |a Krämer, Alwin  |m 1067780025:Krämer, Alwin  |d 910000  |d 910100  |e 910000PK1067780025  |e 910100PK1067780025  |k 0/910000/  |k 1/910000/910100/  |p 19 
998 |g 138282013  |a Sauer, Tim  |m 138282013:Sauer, Tim  |d 910000  |d 910100  |e 910000PS138282013  |e 910100PS138282013  |k 0/910000/  |k 1/910000/910100/  |p 4 
999 |a KXP-PPN1880352532  |e 4479810390 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"6 S.","noteIll":"Illustrationen"}],"id":{"eki":["1880352532"],"doi":["10.3324/haematol.2022.281636"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online verfügbar: 9. Februar 2023","Gesehen am 08.02.2024"],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["99.2014 -"],"titleAlt":[{"title":"journal of the European Hematology Association"}],"language":["eng"],"recId":"814204899","disp":"Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations results of the SAL MIDOKIT trial : letter to the editorHaematologica","note":["Gesehen am 27.05.2022"],"part":{"extent":"6","issue":"9","year":"2023","pages":"2520-2525","volume":"108","text":"108(2023), 9 vom: Sept., Seite 2520-2525"},"id":{"eki":["814204899"],"issn":["1592-8721"],"zdb":["2805244-4"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title_sort":"Haematologica"}],"origin":[{"dateIssuedDisp":"2014-","publisher":"Ferrata Storti Foundation","publisherPlace":"Pavia","dateIssuedKey":"2014"}]}],"person":[{"role":"aut","display":"Ruhnke, Leo","given":"Leo","family":"Ruhnke"},{"family":"Röllig","given":"Christoph","display":"Röllig, Christoph","role":"aut"},{"family":"Herold","given":"Sylvia","display":"Herold, Sylvia","role":"aut"},{"role":"aut","family":"Sauer","display":"Sauer, Tim","given":"Tim"},{"role":"aut","family":"Brandts","given":"Christian Hubertus","display":"Brandts, Christian Hubertus"},{"display":"Steffen, Björn","given":"Björn","family":"Steffen","role":"aut"},{"family":"Schäfer-Eckart","display":"Schäfer-Eckart, Kerstin","given":"Kerstin","role":"aut"},{"family":"Krause","given":"Stefan W.","display":"Krause, Stefan W.","role":"aut"},{"display":"Hänel, Mathias","given":"Mathias","family":"Hänel","role":"aut"},{"role":"aut","family":"Reichle","given":"Albrecht","display":"Reichle, Albrecht"},{"display":"Scholl, Sebastian","given":"Sebastian","family":"Scholl","role":"aut"},{"role":"aut","family":"Neubauer","display":"Neubauer, Andreas","given":"Andreas"},{"given":"Jan-Henrik","display":"Mikesch, Jan-Henrik","family":"Mikesch","role":"aut"},{"given":"Johannes","display":"Schetelig, Johannes","family":"Schetelig","role":"aut"},{"given":"Friedrich","display":"Stölzel, Friedrich","family":"Stölzel","role":"aut"},{"family":"Kramer","given":"Michael","display":"Kramer, Michael","role":"aut"},{"given":"Annett","display":"Haake, Annett","family":"Haake","role":"aut"},{"display":"Frimmel, Julia","given":"Julia","family":"Frimmel","role":"aut"},{"role":"aut","family":"Krämer","display":"Krämer, Alwin","given":"Alwin"},{"role":"aut","given":"Richard Friedrich","display":"Schlenk, Richard Friedrich","family":"Schlenk"},{"family":"Platzbecker","given":"Uwe","display":"Platzbecker, Uwe","role":"aut"},{"role":"aut","display":"Serve, Hubert","given":"Hubert","family":"Serve"},{"role":"aut","family":"Baldus","given":"Claudia","display":"Baldus, Claudia"},{"role":"aut","family":"Müller-Tidow","given":"Carsten","display":"Müller-Tidow, Carsten"},{"role":"aut","family":"Aust","display":"Aust, Daniela E.","given":"Daniela E."},{"role":"aut","display":"Bornhäuser, Martin","given":"Martin","family":"Bornhäuser"},{"role":"aut","family":"Ehninger","display":"Ehninger, Gerhard","given":"Gerhard"},{"role":"aut","given":"Christian","display":"Thiede, Christian","family":"Thiede"}],"origin":[{"dateIssuedDisp":"September, 2023","dateIssuedKey":"2023"}],"name":{"displayForm":["Leo Ruhnke, Christoph Röllig, Sylvia Herold, Tim Sauer, Christian H. Brandts, Björn Steffen, Kerstin Schäfer-Eckart, Stefan W. Krause, Mathias Hänel, Albrecht Reichle, Sebastian Scholl, Andreas Neubauer, Jan-Henrik Mikesch, Johannes Schetelig, Friedrich Stölzel, Michael Kramer, Annett Haake, Julia Frimmel, Alwin Krämer, Richard Schlenk, Uwe Platzbecker, Hubert Serve, Claudia D. Baldus, Carsten Müller-Tidow, Daniela Aust, Martin Bornhäuser, Gerhard Ehninger and Christian Thiede on behalf of the Study Alliance Leukemia (SAL)"]},"recId":"1880352532","title":[{"title":"Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations","subtitle":"results of the SAL MIDOKIT trial : letter to the editor","title_sort":"Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations"}],"language":["eng"]} 
SRT |a RUHNKELEORMIDOSTAURI2023